Form 8-K - Current report:
SEC Accession No. 0001140361-25-007884
Filing Date
2025-03-10
Accepted
2025-03-10 16:48:12
Documents
16
Period of Report
2025-03-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20045156_8k.htm   iXBRL 8-K 40727
2 EXHIBIT 99.1 ef20045156_ex99-1.htm EX-99.1 19123
6 image0.jpg GRAPHIC 320774
7 image00002.jpg GRAPHIC 2324
  Complete submission text file 0001140361-25-007884.txt   1060560

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ngvt-20250310.xsd EX-101.SCH 3982
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ngvt-20250310_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ngvt-20250310_pre.xml EX-101.PRE 16044
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20045156_8k_htm.xml XML 4065
Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Filer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37586 | Film No.: 25724472
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)